Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis

Cochrane Database of Systematic Reviews

Volumn 2008, Issue 4, 2006, Pages

  Paramothayan, N Shanthi ^a   Lasserson, Toby J ^b   Walters, E Haydn ^c  

^a ST HELIER HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOROQUINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SARCOIDOSIS;

ANTINEOPLASTIC AGENTS; CHLOROQUINE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE; RANDOMIZED CONTROLLED TRIALS; SARCOIDOSIS, PULMONARY;

EID: 33750140458     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003536.pub2     Document Type: Review

References (49)

1. Baltzan M, Mehta S, Kirkham T, Cosio M. Randomised trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine 1999;160:192-197.
2. Baughman RP, Winget D, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2000;17:60-66.
3. British Tuberculosis Association. Chloroquine in the treatment of sarcoidosis. Tubercle 1967;48:257-72.
4. Manganiello VC, Park MK, Stylianou M, Litzenberger R, Jackson K, Tsygansky Y, et al. A randomized trial of pentoxifylline in pulmonary sarcoidosis. American Thoracic Society 2005 International Conference; May 20-25; San Diego, California. 2005:A14.
5. NHLBI. Treatment of pulmonary sarcoidosis with pentoxifylline [Protocol 99-H-0057]. clinicaltrials.gov 2005.
6. Wyser C, van Schalkwyk E, Bardin PG. Treatment of chronic sarcoidosis with cyclosporin. Schweizerische Medizinische Wochenschrift 1996;126(17 Suppl):75.
7. Wyser C, van Schalwyk E, Alheit B, Bardin P, Joubert J. Treatment of progressive pulmonary sarcoidosis with Cyclosporin A: a RCT. American Journal of Respiratory and Critical Care Medicine 1997;157:1371-6.
8. Adams J. Effective reduction in the serum 1,23-Dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcaemia with short-course chloroquine therapy. Annals of Internal Medicine 1989;111(5):437-8.
9. American Thoracic Society. Statement on sarcoidosis. American Journal of Respiratory and Critical Care Medicine 1999;160:736-55.
10. Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. American Review of Respiratory Disease 1990;142(6):1268-71.
11. Baughman B, Lower E. Infliximab for refractory sarcoidosis. Sarcoidosis vasculitis and diffuse lung diseases 2001;18:70-4.
12. Conron M, Lewis Clarke Benyon H. Ketoconazole for the treatment of refractory hypercalcaemic sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2000;17:277-80.
13. Demeter S. Myocardial sarcoidosis unresponsive to steroids. Chest 1998;94(1):202-3.
14. Estines O, Revuz J, Bressieux J-M, Roujeau J-C, Cosnes A. Sarcoidosis: thalidomide therapy in 10 patients [Sarcoidose: traitement par thalidomide chez 10 malades]. Annales de Dermatologie et de Venereologie 2001;128(5):611-3.
15. Fanburg B. Drug therapy reviews: Treatment of sarcoidosis. American Journal of Hospital Pharamacology 1979;36:351-59.
16. Flaherty KR, Toews GB, Lynch JP, Kazerooni EA, Gross BH, Strawderman RL, et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. American Journal of Medicine 2001;110(4):278-82.
17. Gibson GJ. Sarcoidosis: old and new treatments. Thorax 2001;56:336-9.
18. Hart LA, Conron M, du Bois RM. Sarcoidosis. International Journal of Tuberculosis and Lung Disease 2001;5(9):791-806.
19. Hof DG, Hof PC, Godfrey WA. Long-term use of Azathioprine as a steroid-sparing treatment. American Journal of Respiratory and Critical Medicine 1996;153:A870.
20. Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, et al. Outcome of the treatment for sarcoidosis. American Journal of Respiratory and Critical Care Medicine 1994;149:893-8.
21. Israel HL, McComb BL. Chlorambucil treatment of sarcoidosis. Sarcoidosis 1991;8:35-41.
22. Johns CJ, Paz H, Kaspar EK, Baughman K. Myocardial sarcoidosis: course and management. Sarcoidosis 1992;9:231-6.
23. Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50 year experience at the Johns Hopkins Hospital. Medicine 1999;78(2):65-111.
24. Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. Journal of the American Academy of Dermatology 1990;23(3 Pt 1):487-9.
25. Kataria Y. Chlorambucil in sarcoidosis. Chest 1980;78(1):36-43.
26. Kavanaugh AF, Andrew SL, Cooper B, Lawrence EC, Huston DP. Cyclosporine therapy of central nervous system sarcoidosis. American Journal of Medicine 1987;82:387.
27. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG. Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. British Journal of Rheumatology 1995;34:642-4.
28. Körber M, Kamp S, Kothe H, Braun J, Dalhoff K. Pentoxifyllin inhibits the secretion of oxygen and TNF via alveolar macrophages in patients with sarcoidosis [Pentoxifyllin hemmt die Sekretion von O2- und TNF durch Alveolarmakrophagen bei Patienten mit Sarkoidose]. Immunität und Infektion 1995;23(3):107-10.
29. Lower E, Baughman R. The use of low dose methotrexate in refractory sarcoidosis. American Journal of the Medical Sciences 1990;299(3):153-7.
30. Lower E, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Archives of Internal Medicine 1995;155:846-51.
31. Lower E, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Archives of Internal Medicine 1997;157(8):1864-8.
32. Martinet Y, Pinkston P, Saltini C, Spurzem J, Muller-Quernheim J, Crystal RG. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. American Review of Respiratory Disease 1988;138(5):1242-8.
33. Müller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. European Respiratory Journal 1999;14:1117-22.
34. Nicholson A, Colby T, Dubois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Respiratory and Critcal Care Medicine 2000;162:2213-7.
35. Pacheco Y, Marechal C, Marechal F, Biot N, Perrin Fayolle M. Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 1985;2(2):107-13.
36. Peuckmann V, Fisch M, Bruera E. Potential novel uses of thalidomide. Drugs 2000;60(2):273-92.
37. Rajendran R, Theertham M, Salgia R, Muthuswamy P. Methotrexate in the treatment of cutaneous sarcoidosis. Sarcoidosis 1994;11:335-8.
38. Sharma O, Hughes DTD, James DG, Naish P. Immnuosuppressive therapy with azathioprine in sarcoidosis. Therapy: Fifth international conference on Sarcoidosis. Prague: Karvola University.
39. Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Archives of Neurology 1998;55(9):1248-54.
40. Siltzbach L, Teirstein A. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Medica Scandinavica 1964;425:302-8.
41. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G, et al. The treatment of neurosarcoidosis with cyclosporine. Archives of Neurology 1992;49(10):1065-72.
42. Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. British Journal of Dermatology 1977;97:213-6.
43. Wilcox A, Bharadwaj P, Sharma O. Bone sarcoidosis. Current Opinion in Rheumatology 2000;12:321-30.
44. Yamamoto Y. Treatment of pulmonary sarcoidosis. Iryo 1968;22(5):625-30.
45. York EL, Kovithavongs T, Man SFP, Rebuck AS, Sproule BJ. Cyclosporine and chronic sarcoidosis. Chest 1990;98:1026-9.
46. Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Amercian Journal of Respiratory Critical Care Medicine 1997;155:1665-9.
47. Zic JA, Horowitz DH, Arzubiaga C, King LE. Treatment of cutaneous sarcoidosis with chloroquine. Archives of Dermatology 1991;127:1034-40.
48. Bandolier. Bias. Bandolier 2000;7(10):1-5.
49. Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomised controlled trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.